Product Description: Pegloxenatide (PEX 168), polyethylene glycol loxenatide, is a long-acting glucagon-like peptide-1 receptor agonist. Pegloxenatide can be used for the research of type 2 diabetes mellitus (T2DM)[1][2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: (C2H4O)n(C2H4O)nC206H317N55O67S
References: [1]Wang J, et al. Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study. Br J Clin Pharmacol. 2019 Dec;85(12):2714-2720./[2]Li XY, et al. Effect of polyethylene Glycol Loxenatide (long-acting GLP-1RA) on lipid, glucose levels and weight in type 2 diabetes mellitus patients with obesity. Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):7996-8003.
CAS Number: 2420483-82-3
Molecular Weight: N/A
Compound Purity: 90.00
Research Area: Metabolic Disease
Solubility: 10 mM in DMSO
Target: GCGR
English
Deutsch
